Most Recent
Keeping experts in the loop and testing their evidence early is critical to avoiding common pitfalls with their evidence, according to solicitors.
Indian generics giant Sun Pharmaceutical has offered to grant Ferring Pharmaceuticals a licence to sell a generic version of its IVF drug to win ACCC approval for its $16.7 billion takeover of US-based Organon.
IMB Bank has been hit with a lawsuit by a Perth-based fintech alleging the mutual bank breached the copyright and a licence agreement for its customer relations management software.
An IP Australia delegate has rejected olive oil maker Cobram Estate’s bid to register a trade mark featuring the phrase 'premium quality great taste', saying other traders should be free to use the label for similar goods.
Closing its case against non-alcoholic beverage maker Noot, Bickford’s has told a judge that descriptive words can constitute trade mark use when they are used to evoke a feeling or mood.
Cipla Australia wants an undertaking it intends to give pharma company Actelion over plans to launch a generic version of a blood pressure drug to be shielded from rivals Arrotex, Nova Pharmaceuticals and MSN Laboratories, as those companies battle patent infringement claims.
UK luggage giant Tripp Limited has lodged an appeal after losing its opposition to a Japanese luggage maker's bid to register 'New Trip' as a trade mark for its luggage line.
Arrotex has secured an exclusive licence to sell Sydney-based biotech Recce Pharmaceuticals’ experimental diabetic foot infection treatment in Australia and New Zealand.
The maker of the popular Maxi-Cosi line of child car seats has lost its opposition to a rival's patent for a child car seat designed to reduce the risk of the safety tether breaking in a crash.
Dozens of media organisations worldwide have joined forces in a letter to Prime Minister Anthony Albanese, slamming proposals to amend copyright laws to allow an exemption for AI companies.